Should a woman with a mildly dyskaryotic cervical smear be referred fo
r colposcopy or should the smear be repeated? One way to answer this q
uestion is to use decision analysis and compare the expected mortality
and cost of each policy. Data for each component of the question were
obtained from published work worldwide and were supplemented with an
audit of mildly dyskaryotic smears in West Yorkshire, UK. 2 out of 100
0 women with an initial mildly dyskaryotic smear will develop cancer i
f a conservative repeat smear policy is adopted in association with fi
ve-yearly cervical screening. This number can be reduced to 1.6 per 10
00 if cervical screening is offered every three years. A policy of imm
ediate referral for colposcopy is also associated with a subsequent ca
ncer rate of 1.6 per 1000. Therefore, repeating the smear is almost as
effective as an immediate referral to a colposcopy unit. Even if a fi
ve-yearly cervical screening programme is adopted, 2500 women with a m
ildly dyskaryotic smear will need to be referred for immediate colposc
opy to save 1 additional cancer. A conservative policy is not financia
lly cheaper: an average of six additional smears is required to save e
ach colposcopy referral. Sensitivity analysis shows that the excess co
st of the conservative policy increases exponentially as the risk of a
subsequent cytological abnormality exceeds 60%. Local cytopathology l
aboratories should audit their recurrent dyskaryosis rate associated w
ith borderline, mild, and moderate dyskaryosis before accepting the U-
tum in the national recommendations.